HLS Therapeutics Inc (OTCPK:HLTRF)
$ 2.73 0.19 (7.48%) Market Cap: 79.01 Mil Enterprise Value: 134.51 Mil PE Ratio: 0 PB Ratio: 1.02 GF Score: 68/100

HLS Therapeutics Inc Annual Shareholders Meeting Transcript

Jun 16, 2023 / 02:00PM GMT
Release Date Price: $4.76
Operator

Welcome to the Annual Meeting of Shareholders of HLS Therapeutics Inc. please note that today's meeting is being recorded. (Operator Instructions) It is now my pleasure to turn today's meeting over to Ryan Lennox, Senior Vice President, Law, HR and Compliance of HLS Therapeutics Inc. Mr. Lennox, the floor is yours.

Ryan C. Lennox
HLS Therapeutics Inc. - Senior VP of Legal, HR & Compliance and Corporate Secretary

Good morning, and welcome to the Annual Meeting of Shareholders of HLS Therapeutics Inc. Thank you to everyone for your attendance today. My name is Ryan Lennox. I'm the Corporate Secretary and the Senior Vice President, Law, HR and Compliance of HLS.

I'd like to briefly read the following statement regarding forward-looking information before turning the meeting over to Greg Gubitz as Chair of the Board. In the course of today's meeting, directors and officers of HLS may, in their remarks or in response to questions, make certain statements that are forward-looking statements and our perspective. Forward-looking statements are neither

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot